Dr. Elizabeth R. Kessler
Claim this profileUniversity of Colorado Hospital
Studies Prostate Cancer
Studies Bladder Cancer
12 reported clinical trials
36 drugs studied
Affiliated Hospitals
Clinical Trials Elizabeth R. Kessler is currently running
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
Durvalumab + Chemotherapy
for Urothelial Carcinoma
This phase II/III trial compares the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery in treating patients with upper urinary tract cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as methotrexate, vinblastine, doxorubicin, cisplatin, and gemcitabine work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Durvalumab in combination with chemotherapy before surgery may enhance the shrinking of the tumor compared to chemotherapy alone.
Recruiting1 award Phase 2 & 310 criteria
More about Elizabeth R. Kessler
Clinical Trial Related4 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Elizabeth R. Kessler has experience with
- Enzalutamide
- Goserelin Acetate
- Docetaxel
- Gemcitabine Hydrochloride
- Axitinib
- Pembrolizumab
Breakdown of trials Elizabeth R. Kessler has run
Prostate Cancer
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Elizabeth R. Kessler specialize in?
Elizabeth R. Kessler focuses on Prostate Cancer and Bladder Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Elizabeth R. Kessler currently recruiting for clinical trials?
Yes, Elizabeth R. Kessler is currently recruiting for 4 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Elizabeth R. Kessler has studied deeply?
Yes, Elizabeth R. Kessler has studied treatments such as Enzalutamide, Goserelin Acetate, Docetaxel.
What is the best way to schedule an appointment with Elizabeth R. Kessler?
Apply for one of the trials that Elizabeth R. Kessler is conducting.
What is the office address of Elizabeth R. Kessler?
The office of Elizabeth R. Kessler is located at: University of Colorado Hospital, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.